NASDAQ · Healthcare · Biotechnology
Seaport Therapeutics, Inc. Common Stock
SPTX
Seaport Therapeutics, Inc. CEO Daphne Zohar · Market cap $1.1B.
$21.40
+2.04 · +10.54%
52w hi $23.0052w lo $14.85
Off 52w high 16.0%
69
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
—
Avg PT $32.50
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 22 | Robert J. Hombach | Buy | 13,000 | $18.14 | +$236K | 55 | |
| May 04 | ARCH Venture Partners XII, LLC | Buy | 1,100,000 | $18.00 | +$19.80M | 69 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun